Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background: Some endogenous hormones have been associated with breast cancer risk, but the nature of these relationships is not fully understood. Methods: UK Biobank was used. Hormone concentrations were measured in serum collected in 2006–2010, and in a repeat subsample ( N ~ 5000) in 2012–13. Incident cancers were identified through data linkage. Cox regression models were used, and hazard ratios (HRs) corrected for regression dilution bias. Results: Among 30,565 pre-menopausal and 133,294 post-menopausal women, 527 and 2,997, respectively, were diagnosed with invasive breast cancer during a median follow-up of 7.1 years. Cancer risk was positively associated with testosterone in post-menopausal women (HR per 0.5 nmol/L increment: 1.18; 95% CI: 1.14, 1.23) but not in pre-menopausal women ( p heterogeneity = 0.03), and with IGF-1 (insulin-like growth factor-1) (HR per 5 nmol/L increment: 1.18; 1.02, 1.35 (pre-menopausal) and 1.07; 1.01, 1.12 (post-menopausal); p heterogeneity = 0.2), and inversely associated with SHBG (sex hormone-binding globulin) (HR per 30 nmol/L increment: 0.96; 0.79, 1.15 (pre-menopausal) and 0.89; 0.84, 0.94 (post-menopausal); p heterogeneity = 0.4). Oestradiol, assessed only in pre-menopausal women, was not associated with risk, but there were study limitations for this hormone. Conclusions: This study confirms associations of testosterone, IGF-1 and SHBG with breast cancer risk, with heterogeneity by menopausal status for testosterone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Because circulating estrogens are associated to an increased breast cancer risk in women, [123][124][125] and this cancer is related to alcohol intake, 126,127”
From The chronic alcohol consumption influences the gonadal axis in men: Results from a meta‐analysis (2024) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · cited 1×
“It may increase the risk of breast cancer by stimulating cell proliferation and inhibiting apoptosis.(17) The effects of IGF-1 on breast cells may be enhanced by oestrogens(18) as it has been proposed that IGF-1 interacts with oestrogen signalling pathways to regulate mitosis, apoptosis, adhesion, migration and differ…”
BackgroundThe Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
(2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70425-4 · Cited by 1,160
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Henderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821 · cited 2×
“Total and calculated free oestradiol in pre-menopausal women Endogenous oestrogens may increase the risk of breast cancer by promoting cell proliferation and decreasing apoptosis.(1) Higher oestradiol concentrations have been consistently associated with an increased risk of post-menopausal breast cancer.”
BackgroundUsing human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Cited by
Prospective study design and data analysis in UK Biobank
Allen, N. E., Lacey, B., Lawlor, D. A., Pell, J. P., Gallacher, J., Smeeth, L., Elliott, P., Matthews, P. M., Lyons, R. A., Whetton, A. D., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adf4428 · Cited by 279
Watling, C. Z., Schmidt, J. A., Dunneram, Y., Tong, T. Y. N., Kelly, R. K., Knüppel, A., Travis, R. C., Key, T. J., & Perez‐Cornago, A. (2022) · BMC Medicine · doi:10.1186/s12916-022-02256-w · Cited by 125
Self-citationSex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study
Nounu, A., Kar, S., Relton, C. L., & Richmond, R. C. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01553-9 · Cited by 72
“Positive associations with premenopausal BC were also found for estradiol, androstenedione, DHEAS and testosterone in a pooled analysis of seven prospective studies including 767 women with BC and 1699 controls [12]; however, a much larger study conducted in UK Biobank among 30,565 premenopausal women and 133,294 post…”
ResultRutter, C. E., Millard, L. A. C., Borges, M. C., & Lawlor, D. A. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad082 · Cited by 50
Ingebriktsen, L. M., Finne, K., Akslen, L. A., & Wik, E. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01953-w · Cited by 36
“To speculate, the increased levels of endogenous oestrogen in premenopausal women may promote cell proliferation and concurrently less apoptosis, also contributing to the increased tumour cell proliferation seen in the young [48, 49].”
Background
Metadata
- Authors
- Tin Tin, S., Reeves, G. K., & Key, T. J.
- Affiliations
- University of Oxford (GB)
- Venue
- British Journal of Cancer
- Published
- 2021-04-16
- Volume
- 125
- Issue
- 1
- Pages
- 126-134
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC8257641
- OpenAlex
- W3155385278
- Cited by
- 71
- References
- 38
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 19 · 2023: 11 · 2022: 12 · 2021: 2
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- British Journal of Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion, cc-by)
- Funders
- Manatu Hauora | Health Research Council of New Zealand (19/031)
- Cancer Research UK (C570/A16491)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- invasive breast cancer, endogenous hormones, testosterone, insulin-like growth factor I, sex hormone-binding globulin, estradiol, menopausal status, premenopausal women, postmenopausal women, breast cancer risk
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, United Kingdom, Humans, Insulin-Like Growth Factor I, Middle Aged, Regression Analysis, Sex Hormone-Binding Globulin, Testosterone, Premenopause, Postmenopause, Biological Specimen Banks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. https://app.cochat.ai/papers/10.1038/s41416-021-01392-z
- The paper
- Tin Tin, S., Reeves, G. K., & Key, T. J. (2021). Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. British Journal of Cancer. https://doi.org/10.1038/s41416-021-01392-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.